American Pharma Mfg. Inc.: FDA Warning Letter, Aug 4, 2026
Status: Unknown as of Oct 16, 2026. Warning letters are informal and advisory, not final agency action. Original on FDA.gov.
- Company
- American Pharma Mfg. Inc. (as published by FDA)
- Letter date
- Aug 4, 2026
- Posted
- Sep 29, 2026
- Office
- Human Foods Program
- Subject
- “CGMP/Dietary Supplement/Adulterated/Misbranded”
- Response
- None posted by FDA as of last check
- Close-out
- None posted by FDA as of last check
- Source
- FDA.gov · retrieved Oct 16, 2026
Get new FDA warning letters by email. One digest a week, free.
Double opt-in: we email you a link to confirm. One-click unsubscribe in every email. You must be at least 18. See our Privacy policy.
Need it same day for your suppliers? Reserve a founding Pro seat.
Text above is quoted or paraphrased from FDA.
Something wrong or out of date? Request a correction. We review correction requests within 5 business days.